Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.
Meeus F, Funeh CN, Awad RM, Zeven K, Autaers D, De Becker A, Van Riet I, Goyvaerts C, Tuyaerts S, Neyns B, Devoogdt N, De Vlaeminck Y, Breckpot K. Meeus F, et al. Among authors: goyvaerts c. J Immunother Cancer. 2024 Nov 19;12(11):e009110. doi: 10.1136/jitc-2024-009110. J Immunother Cancer. 2024. PMID: 39562005
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Ceuppens H, Pombo Antunes AR, Navarro L, Ertveldt T, Berdal M, Nagachinta S, De Ridder K, Lahoutte T, Keyaerts M, Devoogdt N, Goyvaerts C, D'Huyvetter M, Breckpot K. Ceuppens H, et al. Among authors: goyvaerts c. Eur J Nucl Med Mol Imaging. 2024 Sep 6. doi: 10.1007/s00259-024-06914-4. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39237746
The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis.
Calderon-Espinosa E, De Ridder K, Benoot T, Jansen Y, Vanhonacker D, Heestermans R, De Becker A, Van Riet I, Decoster L, Goyvaerts C. Calderon-Espinosa E, et al. Among authors: goyvaerts c. Front Immunol. 2024 Aug 1;15:1397469. doi: 10.3389/fimmu.2024.1397469. eCollection 2024. Front Immunol. 2024. PMID: 39148724 Free PMC article. Review.
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Hanssens H, Meeus F, De Vlaeminck Y, Lecocq Q, Puttemans J, Debie P, De Groof TWM, Goyvaerts C, De Veirman K, Breckpot K, Devoogdt N. Hanssens H, et al. Among authors: goyvaerts c. Front Immunol. 2024 Apr 19;15:1389018. doi: 10.3389/fimmu.2024.1389018. eCollection 2024. Front Immunol. 2024. PMID: 38720898 Free PMC article.
Editorial: Rising stars in cancer immunity and immunotherapy 2022.
Goyvaerts C, Engeland CE, Van der Jeught K. Goyvaerts C, et al. Front Immunol. 2023 Nov 7;14:1326374. doi: 10.3389/fimmu.2023.1326374. eCollection 2023. Front Immunol. 2023. PMID: 38022618 Free PMC article. No abstract available.
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine.
Ertveldt T, Meulewaeter S, De Vlaeminck Y, Olarte O, Broos K, Van Calenbergh S, Bourgeois S, Deprez J, Heremans Y, Goyvaerts C, Staels W, De Smedt S, Dewitte H, Devoogdt N, Keyaerts M, Verbeke R, Barbé K, Lentacker I, Breckpot K. Ertveldt T, et al. Among authors: goyvaerts c. Theranostics. 2023 Oct 9;13(15):5483-5500. doi: 10.7150/thno.85106. eCollection 2023. Theranostics. 2023. PMID: 37908728 Free PMC article.
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
Ertveldt T, Krasniqi A, Ceuppens H, Puttemans J, Dekempeneer Y, Jonghe K, Mey W, Lecocq Q, Vlaeminck Y, Awad RM, Goyvaerts C, Veirman K, Morgenstern A, Bruchertseifer F, Keyaerts M, Devoogdt N, D'Huyvetter M, Breckpot K. Ertveldt T, et al. Among authors: goyvaerts c. J Nucl Med. 2023 May;64(5):751-758. doi: 10.2967/jnumed.122.264752. Epub 2023 Apr 13. J Nucl Med. 2023. PMID: 37055223 Free article.
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Kiss M, Lebegge E, Murgaski A, Van Damme H, Kancheva D, Brughmans J, Scheyltjens I, Talebi A, Awad RM, Elkrim Y, Bardet PMR, Arnouk SM, Goyvaerts C, Swinnen J, Nana FA, Van Ginderachter JA, Laoui D. Kiss M, et al. Among authors: goyvaerts c. Front Immunol. 2022 Dec 1;13:1003975. doi: 10.3389/fimmu.2022.1003975. eCollection 2022. Front Immunol. 2022. PMID: 36531986 Free PMC article.
47 results